Kamila_Reid Posted - 1 day ago

$ACRV $AMRN $ENTA LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

Estimize Posted - 1 day ago

Wall St is expecting -1.16 EPS for $ENTA Q4 [Reporting 11/25 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=eps&utm_c

PenkeTrading Posted - 5 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Enanta Pharmaceuticals Inc. Is that bullish or bearish? $ENTA #Enanta #RsiOversold #NASDAQ

PaidPumper420 Posted - 1 week ago

$ENTA Glad I sold for like $12 profit 🤣

Shay_Mat Posted - 1 week ago

MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. Low Float only 29M outstanding shares. Any buy-in will make this fly to the moon. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead. 8.Offering Deal $AMRN $ENTA

Estimize Posted - 2 weeks ago

Wall St is expecting -1.16 EPS for $ENTA Q4 [Reporting 11/25 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=eps&utm_c

PaidPumper420 Posted - 2 weeks ago

$ENTA Nibbled, finally started a position. Feeling lucky!

Fisher_B Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $ENTA $CMPX $ATYR $TSVT

Estimize Posted - 10/28/24

Wall St is expecting 17.99 revenue for $ENTA Q4 [Reporting 11/25 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=reven

anjalimahesh Posted - 4 weeks ago

$BMY $EGRX $ELTP $ENTA $ZBH

Telefon Posted - 1 month ago

$ELTP Elite Pharmaceuticals just received approval from the Israeli Ministry of Health to sell its generic version of Adderall through Dexcel Pharma. ELTP is now international and could expand into other foreign markets. The share price has risen almost 60% in the last two weeks, and the company is poised for more spectacular growth. Don't miss your opportunity to profit from the meteoric rise of Elite Pharmaceuticals! $EGRX $ENTA $ZBH $BMY

justiceforb_85 Posted - 1 month ago

$ENTA appears to be furthest along in development for RSV treatment (versus prophylaxis from monoclonal antibodies)?

Rickyrickz70 Posted - 09/26/24

$ENTA lets see if this bad boy can run

DonCorleone77 Posted - 09/26/24

$ENTA Enanta's EDP-323 meets Phase 2a endpoints in respiratory syncytial virus Enanta Pharmaceuticals announced positive topline results from a Phase 2a human challenge study of EDP-323 in healthy adults infected with respiratory syncytial virus - RSV -. These data demonstrated that EDP-323 was generally safe and well-tolerated and achieved an 85-87% reduction in viral load area under the curve - AUC - by qRT-PCR, a 97-98% reduction in infectious viral load AUC by viral culture, and a 66-78% reduction of total clinical symptoms score AUC vs. placebo. EDP-323, which received Fast Track designation from the FDA, is a novel L-protein inhibitor in development as a once-daily oral treatment for RSV. EDP-323 demonstrated a rapid and sustained antiviral effect. EDP-323 demonstrated favorable pharmacokinetics, supportive of once-daily dosing. Overall, EDP-323 demonstrated a favorable safety profile over a 5-day dosing period and through 28 days of follow-up. Adverse events were similar between EDP-323 dosing groups and placebo. There were no serious adverse events, no severe adverse events, and no adverse events leading to treatment discontinuation or study withdrawal.

Stock_Titan Posted - 09/26/24

$ENTA Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) https://www.stocktitan.net/news/ENTA/enanta-pharmaceuticals-announces-positive-topline-results-for-edp-nn68l1h9boxa.html

DonCorleone77 Posted - 3 months ago

$ENTA Enanta Pharmaceuticals reports Q3 EPS ($1.07), consensus ($1.45) Reports Q3 revenue $18M, consensus $17.18M. "We are thrilled to announce that we have completed enrollment of RSVPEDs, our first-in-pediatrics study of zelicapavir, an N-protein inhibitor, and anticipate reporting topline data next quarter. We thank all the patients, caregivers and investigators involved in this important study for pediatric health," said Jay R. Luly, Ph.D., President and Chief Executive Officer at Enanta Pharmaceuticals. "This is a key milestone in the ongoing advancement of our robust clinical RSV portfolio, aimed at addressing the significant unmet need in populations at high risk for severe outcomes from RSV. As we advance two potentially first-in-class oral antiviral replication inhibitors with differentiated mechanisms of action, our potent L-protein inhibitor, EDP-323, has completed the Phase 2a human challenge study and we remain on track to announce topline data this quarter."

epsguid Posted - 3 months ago

$ENTA reported a loss of $1.07, consensus was ($1.49) via @eWhispers #epsbeat http://eps.sh/d/enta

Stock_Titan Posted - 3 months ago

$ENTA Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter https://www.stocktitan.net/news/ENTA/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-j5y56i3l0x5w.html

NVDAMillionaire Posted - 07/31/24

$ENTA Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA): Advancing a Robust Pipeline to Address Unmet Needs in Virology and Immunology http://beyondspx.com/2024/07/29/enanta-pharmaceuticals-inc-nasdaqenta-advancing-a-robust-pipeline-to-address-unmet-needs-in-virology-and-immunology/

Doozio Posted - 07/30/24

$ENVA dips are a 🎁 TTWO $enta if yo 👀 $it in 🧠⏰♾️

Doozio Posted - 07/24/24

Chop chop huckleberries. If no faatch 💣 it’s $enta 🧠⏰

PeedyWeedy Posted - 4 months ago

$ENTA Is p1 data in RSV gonna move the needle?

insiderbuyingselling Posted - 4 months ago

$ENTA new insider selling: 11945 shares. http://insiderbuyingselling.com/?t=ENTA

Rider_on_the_Stonk Posted - 4 months ago

$ENTA things were moving up too fast. I sold $20 calls for Oct 18 for $100 premium. My average is just over 18. Good luck all!

Doozio Posted - 4 months ago

Spreads $intr da 🐑 then $enta all MNKD during 🧠⏰♾️

Rider_on_the_Stonk Posted - 4 months ago

$ENTA how are people doing here? Just waiting on news and a big spike?

InsiderPeek Posted - 5 months ago

$ENTA Chief Product Strategy Officer Kieffer Tara Lynn sold 7.3k shares for $89.6k (ownership down 18.35%) insiderpeek.com/company/ENTA

insiderbuyingselling Posted - 5 months ago

$ENTA new insider selling: 7266 shares. http://insiderbuyingselling.com/?t=ENTA

wajtrading Posted - 5 months ago

grabbing some $ENTA today. Good company. Priced above MA200. Crossed MA50 the other day as well. High institutional holdings.

Aigner_Andreas Posted - 05/30/24

TD BUY $ENTA at 12.00, Supp 11.90 Resis 13.34 R12 HiLo 21% T1Y 73 buy 2.2 DIV N/A #Enanta Pha #stocks #trading #finance #market